Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Nicholas Allen Forward, MDMSc,FRCPC, Pierre Laneuville, MD FRCPC, Joy Mangel, MD FRCPC, Douglas A. Stewart, MD FRCPC, Irina Amitai, MD, Gail Klein, MSc, Nancy Pennell, BSc, Iran Rashedi, MD MSc, Kim Roos, BA, BSc, Yogesh Bramhecha, Rebekah Conlon, RN

Blood (2020) 136 (Supplement 1): 16.

https://doi.org/10.1182/blood-2020-136751

Published: 2020

Journal Articles

Generalizability of Landmark Clinical Trials in Diffuse Large B Cell Lymphoma to Real-World Patients: A Single-Centre Retrospective Cohort Study

Marta Davidson, MDPhDFRCPC, Alexandra Rice, MD, Douglas A. Stewart, MD FRCPC, Carolyn Owen, MDFRCPC

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-137541

Published: 2020

Journal Articles

Real World Characteristics and Outcomes of Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma; A Provincial Experience

Farheen Manji, MD, Douglas A. Stewart, MD FRCPC

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-139850

Published: 2020

Journal Articles

Plasmablastic Lymphoma: Synergism between Wnt/B-Catenin and the RAS S ignalling Molecules May Identify Potential Targets for Therapy

Hamza Kamran, BSc, Ariz Akhter, PhD, Hassan Rizwan, B.Sc, Meer-Taher Shahbani-Rad, MDFRCPC, Ghaleb Elyamany, MDPhD FRCPC, Douglas A. Stewart, MD FRCPC, Adnan Mansoor, MDFRCPC

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-140651

Published: 2020

Journal Articles

Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

Robert Puckrin, MD, Haidar El Darsa, MD, Sunita Ghosh, PhD P Stat, Anthea Peters, MSc, MD FRCPC, Douglas A. Stewart, MD FRCPC

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-139025

Published: 2020

Journal Articles

Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis

Blood (2016) 128 (22): 4651.

https://doi.org/10.1182/blood.V128.22.4651.4651

Published: 2016

Journal Articles

Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study

Sonia Cerquozzi, MD FRCPC, Sunita Ghosh, PhD, P.Stat., Diana Quinlan, Amy Trottier, MD, Mary Lynn Savoie, MD FRCPC, Douglas A. Stewart, MD FRCPC, James A. Russell, MD FRCPC, Carolyn Owen, MD MDes (UK), FRCPC

Blood (2015) 126 (23): 5530.

https://doi.org/10.1182/blood.V126.23.5530.5530

Published: 2015

Journal Articles

Gene-Expression for Prediction of Disease Progression Following Initial Management of Follicular Lymphoma

Etienne Mahe, BSc, MD FRCPC, Ariz Akhter, PhD, Danielle H. Oh, MB ChB, Fahad Farooq, BSc, Meer-Taher Shabani-Rad, MD FRCPC, Adnan Mansoor, MD FRCPC, Douglas A. Stewart, MD FRCPC

Blood (2015) 126 (23): 4804.

https://doi.org/10.1182/blood.V126.23.4804.4804

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation Improves Survival for Patients with Follicular Lymphoma in First or Second Relapse: Results of a Comparative Effectiveness Instrumental Variable Analysis

Danielle H. Oh, MB ChB, Qiuli Duan, MSc, Anthea Peters, MD MSc, FRCPC, Neil Chua, MD FRCPC, Douglas A. Stewart, MD FRCPC

Blood (2014) 124 (21): 3972.

https://doi.org/10.1182/blood.V124.21.3972.3972

Published: 2014

Journal Articles

BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

Wilson Lam, MD, Jan Storek, MD PhD, Nizar J Bahlis, MD, Christopher Brown, MD, Peter Duggan, MD FRCPC, Michelle Geddes, MD FRCPC, Mary Lynn Savoie, MD FRCPC, Mona Shafey, MD FRCPC, Douglas A. Stewart, MD FRCPC, Andrew Daly, MD FRCPC

Blood (2014) 124 (21): 3901.

https://doi.org/10.1182/blood.V124.21.3901.3901

Published: 2014

Journal Articles

Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients <65 Years of Age

Joanna Graczyk, MD FRCPC, Sunita Ghosh, PhD, Neil Chua, MD FRCPC, Douglas A. Stewart, MD FRCPC, Carolyn J. Owen, MD FRCPC

Blood (2014) 124 (21): 2520.

https://doi.org/10.1182/blood.V124.21.2520.2520

Published: 2014

Journal Articles

Evaluation Of a Novel 3 Factor Prognostic Score (PS-3) For Patients With Advanced Hodgkin Lymphoma (HL) Treated On US Intergroup E2496

Blood (2013) 122 (21): 4277.

https://doi.org/10.1182/blood.V122.21.4277.4277

Published: 2013

Journal Articles

Final Report Of a Phase II Clinical Trial Of Lenalidomide Monotherapy For T-Cell Lymphoma

Ethan Toumishey, B. Sc, Angeli Prasad, CCRP, Gregory S. Dueck, MD, MSc, BSc, FRCPC, Neil Chua, MD, FRCPC, Daygen Finch, MD, Douglas A. Stewart, MD, FRCPC, Darrell J. White, MD, Richard H. van der Jagt, MD, FRCPC, James B Johnston, MD, Andrew R Belch, MD, Tony Reiman, MD

Blood (2013) 122 (21): 4376.

https://doi.org/10.1182/blood.V122.21.4376.4376

Published: 2013

Journal Articles

Prolonged Survival in Secondary CNS Lymphoma Following High Dose Thiotepa/Busulfan-Based Chemotherapy (HDTB) and Autologous Stem Cell Transplantation (ASCT): Single Institution Results From Calgary, Canada

Lesley E. Street, MD, FRCPC, Nizar J. Bahlis, MD, Karen Valentine, MD, PhD, Deirdre A. Jenkins, MD, FRCPC, Carolyn J Owen, MD, FRCPC, Mona Shafey, MD, FRCPC, Peter Duggan, MD, FRCPC, Douglas A. Stewart, MD, FRCPC

Blood (2012) 120 (21): 2003.

https://doi.org/10.1182/blood.V120.21.2003.2003

Published: 2012

Journal Articles

High Cereblon Protein Expression Correlates with Improved Response and Survival in Myeloma Patients Treated with Lenalidomide

Alexander Klimowicz, PhD, Paola Neri, MD, PhD, Andrew Belch, MD, Michelle Dean, Li Ren, PhD, Kathy Gratton, Jiri Slaby, MD, Jordan Johnson, Peter Duggan, MD, FRCPC, Douglas A. Stewart, MD, FRCPC, Nizar J. Bahlis, MD

Blood (2012) 120 (21): 931.

https://doi.org/10.1182/blood.V120.21.931.931

Published: 2012

Journal Articles

Gaps in Access to Patient Care for Patients with Rare Hematological Disorders

Renee Lachance, B.MOS, Douglas A. Stewart, MD, FRCPC, Katie Worthington, HB.Sc., MBiotech, Beena Mistry, B.Sc., MBA, Simon Yunger, MBA, Jose M Garnica, PhD, MBA, Shelagh Knight, RN, OCN, Debbie Milliken, BScPhm

Blood (2011) 118 (21): 4752.

https://doi.org/10.1182/blood.V118.21.4752.4752

Published: 2011

Journal Articles

Interim Restaging PET/CT-Guided High Dose Sequential Induction Therapy with Autologous Stem Cell Transplantation (ASCT) Does Not Improve Outcome for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials.Gov Identifier: NCT00530179

Douglas A. Stewart, MD, FRCPC, Reinhard Kloiber, MD, FRCPC, Nizar Bahlis, MD, Peter Duggan, MD, FRCPC, Andrew Daly, MD, FRCPC, Christian Fibich, MD, David Blair Macdonald, MD, FRCPC, Isabelle Bence-Bruckler, MD, FRCPC

Blood (2011) 118 (21): 500.

https://doi.org/10.1182/blood.V118.21.500.500

Published: 2011

Journal Articles

Integrin β7-Mediated Regulation of Multiple Myeloma Cell Adhesion, Migration and Survival.

Paola Neri, M.D., Li Ren, Ph.D., Kathy Gratton, Alex Klimowicz, Ph.D., Adnan Mansoor, MD, FRCPC, Douglas A. Stewart, MD, FRCPC, Nizar J Bahlis, MD

Blood (2009) 114 (22): 949.

https://doi.org/10.1182/blood.V114.22.949.949

Published: 2009

Journal Articles

FluBup-ATG-TBI for High-Risk or Advanced Adult ALL in Remission: A Retrospective Review of a Mature Cohort.

Andrew Daly, MD, FRCPC, Douglas A. Stewart, MD, FRCPC, Ahsan Chaudhry, MD, Nizar J Bahlis, MD, FRCPC, Christopher Brown, MD, FRCPC, Peter Duggan, MD, FRCPC, Michelle Geddes, MD, FRCPC, Mary Lynn Savoie, MD, FRCPC, Jan Storek, MD, PhD, Maggie Yang, James A. Russell, MD, FRCPC

Blood (2009) 114 (22): 3384.

https://doi.org/10.1182/blood.V114.22.3384.3384

Published: 2009

Journal Articles

Interim Restaging FDG-PET/CT to Guide Use of High Dose Sequential Induction Therapy with Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (RDICEP) and Rituximab-Carmustine, Etoposide, Cytarabine, Melphalan (RBEAM) and Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials. Gov Identifier: NCT00530179.

Douglas A. Stewart, MD, FRCPC, Peter Duggan, MD, FRCPC, Nizar J Bahlis, MD, Andrew Daly, MD, FRCPC, Michelle Geddes, MD, FRCPC, Reinhard Kloiber, MD, FRCPC, Christian Fibich, MD, David Blair Macdonald, MD, FRCPC, Isabelle Bence-Bruckler, MD, FRCPC

Blood (2009) 114 (22): 3414.

https://doi.org/10.1182/blood.V114.22.3414.3414

Published: 2009

NARROW

Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Generalizability of Landmark Clinical Trials in Diffuse Large B Cell Lymphoma to Real-World Patients: A Single-Centre Retrospective Cohort Study

Real World Characteristics and Outcomes of Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma; A Provincial Experience

Plasmablastic Lymphoma: Synergism between Wnt/B-Catenin and the RAS S ignalling Molecules May Identify Potential Targets for Therapy

Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis

Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study

Gene-Expression for Prediction of Disease Progression Following Initial Management of Follicular Lymphoma

Autologous Stem Cell Transplantation Improves Survival for Patients with Follicular Lymphoma in First or Second Relapse: Results of a Comparative Effectiveness Instrumental Variable Analysis

BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients <65 Years of Age

Evaluation Of a Novel 3 Factor Prognostic Score (PS-3) For Patients With Advanced Hodgkin Lymphoma (HL) Treated On US Intergroup E2496

Final Report Of a Phase II Clinical Trial Of Lenalidomide Monotherapy For T-Cell Lymphoma

Prolonged Survival in Secondary CNS Lymphoma Following High Dose Thiotepa/Busulfan-Based Chemotherapy (HDTB) and Autologous Stem Cell Transplantation (ASCT): Single Institution Results From Calgary, Canada

High Cereblon Protein Expression Correlates with Improved Response and Survival in Myeloma Patients Treated with Lenalidomide

Gaps in Access to Patient Care for Patients with Rare Hematological Disorders

Interim Restaging PET/CT-Guided High Dose Sequential Induction Therapy with Autologous Stem Cell Transplantation (ASCT) Does Not Improve Outcome for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials.Gov Identifier: NCT00530179

Integrin β7-Mediated Regulation of Multiple Myeloma Cell Adhesion, Migration and Survival.

FluBup-ATG-TBI for High-Risk or Advanced Adult ALL in Remission: A Retrospective Review of a Mature Cohort.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only